Abstract: A method of generating hydrogen from an offgas includes obtaining the offgas from a renewable diesel unit (RDU). The method further includes inputting the offgas to a steam methane reformer (SMR).

Abstract: The invention relates to polynucleotides coding for the PPVO viral genome, to fragments of the polynucleotides coding for the PPVO genome and to polynucleotides coding for individual open reading frames (ORFs) of the PPVO viral genome. The invention also relates to recombinant proteins expressed from the above mentioned polynucleotides and to fragments of said recombinant proteins, and to the use of said recombinant proteins or fragments for the preparation of pharmaceutical compositions.

Abstract: The invention relates to polynucleotides coding for the PPVO viral genome, to fragments of the polynucleotides coding for the PPVO genome and to polynucleotides coding for individual open reading frames (ORFs) of the PPVO viral genome. The invention also relates to recombinant proteins expressed from the above mentioned polynucleotides and to fragments of said recombinant proteins, and to the use of said recombinant proteins or fragments for the preparation of pharmaceutical compositions.

Abstract: The invention relates to polynucleotides coding for the PPVO viral genome, to fragments of the polynucleotides coding for the PPVO genome and to polynucleotides coding for individual open reading frames (ORFs) of the PPVO viral genome. The invention also relates to recombinant proteins expressed from the above mentioned polynucleotides and to fragments of said recombinant proteins, and to the use of said recombinant proteins or fragments for the preparation of pharmaceutical compositions.

Abstract: Viral VEGF and viral anti-inflammatory cytokine compositions, methods of treatment using them, and kits containing them for use in the promotion and/or improvement of wound healing and/or tissue repair, and for anti-scarring, anti-inflammatory, anti-fibrosis and anti-adhesion indications.

Abstract: Viral VEGF and viral anti-inflammatory cytokine compositions, methods of treatment using them, and kits containing them for use in the promotion and/or improvement of wound healing and/or tissue repair, and for anti-scarring, anti-inflammatory, anti-fibrosis and anti-adhesion indications.

Abstract: Methods and apparatuses for routing voice Internet Protocol (IP) packet to a selected processor are described herein. The methods may include initially receiving at a digital baseband receiver of a device a plurality of IP packets. After receiving the IP packets, the digital baseband receiver may determine whether the IP packets are voice or non-voice IP packets. If the IP packets are determined to be non-voice IP packets, the digital baseband receiver may route the non-voice IP packets to a first processor for processing. On the other hand, if the IP packets are determined to be voice IP packets, the digital baseband receiver may route the voice IP packets to a second processor for processing.

Abstract: Embodiments of systems, apparatuses, and methods for emulating an input/output Advanced Programmable Interrupt Controller are disclosed. In one embodiment, an apparatus includes a first interrupt controller having a first programming model, and emulation logic to emulate a second interrupt controller having a second programming model that is different from the first programming model. The emulation logic is also to mask one of a plurality of interrupt requests to the first interrupt controller for each of the plurality of interrupt requests handled by the emulation logic.

Abstract: The invention relates to polynucleotides coding for the PPVO viral genome, to fragments of the polynucleotides coding for the PPVO genome and to polynucleotides coding for individual open reading frames (ORFs) of the PPVO viral genome. The invention also relates to recombinant proteins expressed from the above mentioned polynucleotides and to fragments of said recombinant proteins, and to the use of said recombinant proteins or fragments for the preparation of pharmaceutical compositions.

Abstract: The invention relates to polynucleotides coding for the PPVO viral genome, to fragments of the polynucleotides coding for the PPVO genome and to polynucleotides coding for individual open reading frames (ORFs) of the PPVO viral genome. The invention also relates to recombinant proteins expressed from the above mentioned polynucleotides and to fragments of said recombinant proteins, and to the use of said recombinant proteins or fragments for the preparation of pharmaceutical compositions.

Abstract: Systems and methods may provide for identifying a workload cycle for a computing platform, wherein the workload cycle is to include a busy duration and an idle duration. Additionally, platform energy consumption information may be determined for the workload cycle, and a frequency setting may be selected for the busy duration based at least in part on the platform energy consumption information.

Abstract: Viral VEGF and viral anti-inflammatory cytokine compositions, methods of treatment using them, and kits containing them for use in the promotion and/or improvement of wound healing and/or tissue repair, and for anti-scarring, anti-inflammatory, anti-fibrosis and anti-adhesion indications.

Abstract: Embodiments of systems, apparatuses, and methods for emulating an input/output Advanced Programmable Interrupt Controller are disclosed. In one embodiment, an apparatus includes a first interrupt controller having a first programming model, and emulation logic to emulate a second interrupt controller having a second programming model that is different from the first programming model, The emulation logic is also to mask one of a plurality of interrupt requests to the first interrupt controller for each of the plurality of interrupt requests handled by the emulation logic.

Abstract: The invention relates to polynucleotides coding for the PPVO viral genome, to fragments of the polynucleotides coding for the PPVO genome and to polynucleotides coding for individual open reading frames (ORFs) of the PPVO viral genome. The invention also relates to recombinant proteins expressed from the above mentioned polynucleotides and to fragments of said recombinant proteins, and to the use of said recombinant proteins or fragments for the preparation of pharmaceutical compositions.

Abstract: An apparatus and method are provided that include providing a transaction data structure, and monitoring the transaction data structure for a predetermined amount of time. A link between a bus device and a host controller may be provided into a low power state in response to the monitored transaction data structure.

Abstract: A method and apparatus are provided that include creating an image of a page descriptor at a universal serial bus (USB) device, transferring the image of the page descriptor to a main memory, modifying a schedule list in a main memory based on the transferred image, identifying an active transaction in the modified schedule list, and providing code data to the USB device from the main memory based on the identified active transaction.

Abstract: An apparatus and method are provided that include providing a transaction data structure, and monitoring the transaction data structure for a predetermined amount of time. A link between a bus device and a host controller may be provided into a low power state in response to the monitored transaction data structure.

Abstract: A method and apparatus are provided that include creating an image of a page descriptor at a universal serial bus (USB) device, transferring the image of the page descriptor to a main memory, modifying a schedule list in a main memory based on the transferred image, identifying an active transaction in the modified schedule list, and providing code data to the USB device from the main memory based on the identified active transaction.

Abstract: Methods and apparatus to manage cache memory are disclosed. In one embodiment, an electronic device comprises a first processing unit, a first cache memory, and a first cache controller, and a power management module, wherein the power management module determines at least one operating parameter for the cache memory and passes the at least one operating parameter for the cache memory to a cache controller. Further, the first cache controller manages the cache memory according to the at least one operating parameter, and the power management module evaluates, in the power management module, operating data for the cache memory from the cache controller, and generates, in the power management module, at least one modified operating parameter for the cache memory based on the operating data for the cache memory from the cache controller.

Abstract: Methods and apparatuses for routing voice Internet Protocol (IP) packet to a selected processor are described herein. The methods may include initially receiving at a digital baseband receiver of a device a plurality of IP packets. After receiving the IP packets, the digital baseband receiver may determine whether the IP packets are voice or non-voice IP packets. If the IP packets are determined to be non-voice IP packets, the digital baseband receiver may route the non-voice IP packets to a first processor for processing. On the other hand, if the IP packets are determined to be voice IP packets, the digital baseband receiver may route the voice IP packets to a second processor for processing.